Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.

David E LeafEdward D SiewMichele F EisengaKarandeep SinghFinnian R Mc CauslandAnand SrivastavaT Alp IkizlerLorraine B WareAdit A GindeJohn A KellumSusan T CrowleyMyles WolfSushrut S Waikar

Published in: Clinical journal of the American Society of Nephrology : CJASN (2018)

Higher FGF23 levels are independently associated with greater mortality in critically ill patients.

Keyphrases

cardiovascular events
risk factors